BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38148953)

  • 1. Transmembrane and Ubiquitin-Like Domain-Containing 1 Promotes Glioma Growth and Indicates Unfavorable Prognosis.
    Liu Y; Cai C; Wu K; Hu L
    Int J Genomics; 2023; 2023():3318171. PubMed ID: 38148953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tmub1 Suppresses Hepatocellular Carcinoma by Promoting the Ubiquitination of ΔNp63 Isoforms.
    Fu H; Zhang Y; Chen J; Zhou B; Chen G; Chen P
    Mol Ther Oncolytics; 2020 Sep; 18():126-136. PubMed ID: 32671188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for Colorectal Cancer.
    Hao T; Yu H; Huang D; Liu Q
    Dis Markers; 2022; 2022():5884531. PubMed ID: 35928927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane and Ubiquitin-Like Domain Containing 1 Protein (TMUB1) Negatively Regulates Hepatocellular Carcinoma Proliferation via Regulating Signal Transducer and Activator of Transcription 1 (STAT1).
    Chen Y; Fu H; Zhang Y; Chen P
    Med Sci Monit; 2019 Dec; 25():9471-9482. PubMed ID: 31827061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMUB1 expression is associated with the prognosis of colon cancer and immune cell infiltration.
    Lu Y; Wang K; Peng Y; Zhang J; Ju Q; Xu Q; Ouyang M; He Z
    PeerJ; 2023; 11():e16334. PubMed ID: 38025742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane and ubiquitin-like domain-containing protein 1 (Tmub1/HOPS) facilitates surface expression of GluR2-containing AMPA receptors.
    Yang H; Takagi H; Konishi Y; Ageta H; Ikegami K; Yao I; Sato S; Hatanaka K; Inokuchi K; Seog DH; Setou M
    PLoS One; 2008 Jul; 3(7):e2809. PubMed ID: 18665261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
    Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
    BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma.
    Xu Z; Xu H; Chen X; Huang X; Tian J; Zhao J; Liu B; Shi F; Wu J; Pu J
    Onco Targets Ther; 2023; 16():819-837. PubMed ID: 37873495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCAAT/enhancer-binding protein β regulates interleukin-6-induced transmembrane and ubiquitin-like domain containing 1 gene expression in hepatocytes.
    Liu M; Yuan T; Liu H; Chen P
    Mol Med Rep; 2014 Oct; 10(4):2177-83. PubMed ID: 25109894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray analysis reveals Tmub1 as a cell cycle-associated protein in rat hepatocytes.
    Fu H; Xu J; Chen J; Li G; Zhao X; Chen P
    Mol Med Rep; 2018 Mar; 17(3):4337-4344. PubMed ID: 29344642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.
    Xu J; Liu F; Li Y; Shen L
    Cell Mol Neurobiol; 2022 Apr; 42(3):709-722. PubMed ID: 32894375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmembrane and ubiquitin-like domain containing 1 (Tmub1) regulates locomotor activity and wakefulness in mice and interacts with CAMLG.
    Zhang W; Savelieva KV; Suwanichkul A; Small DL; Kirkpatrick LL; Xu N; Lanthorn TH; Ye GL
    PLoS One; 2010 Jun; 5(6):e11261. PubMed ID: 20582322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
    Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
    Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological analysis of HOXD4 expression in diffuse gliomas and its correlation with
    Zhao XW; Zhan YB; Bao JJ; Zhou JQ; Zhang FJ; Bin Y; Bai YH; Wang YM; Zhang ZY; Liu XZ
    Oncotarget; 2017 Dec; 8(70):115657-115666. PubMed ID: 29383189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation.
    Shi C; Wang Y; Wu M; Chen Y; Liu F; Shen Z; Wang Y; Xie S; Shen Y; Sang L; Zhang Z; Gao Z; Yang L; Qu L; Yang Z; He X; Guo Y; Pan C; Che J; Ju H; Liu J; Cai Z; Yan Q; Yu L; Wang L; Dong X; Xu P; Shao J; Liu Y; Li X; Wang W; Zhou R; Zhou T; Lin A
    Nat Commun; 2022 Nov; 13(1):6951. PubMed ID: 36376293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interfering with
    Gu S; Shu L; Zhou L; Wang Y; Xue H; Jin L; Xia Z; Dai X; Gao P; Cheng H
    Ann Transl Med; 2022 Dec; 10(23):1277. PubMed ID: 36618798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 induction of hepatocyte proliferation through the Tmub1-regulated gene pathway.
    Liu M; Liu H; Wang X; Chen P; Chen H
    Int J Mol Med; 2012 Jun; 29(6):1106-12. PubMed ID: 22426572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tmub1 negatively regulates liver regeneration via inhibiting STAT3 phosphorylation.
    Fu H; Dong R; Zhang Y; Xu J; Liu M; Chen P
    Cell Signal; 2019 Mar; 55():65-72. PubMed ID: 30610893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of TMUB1 blocks apoptosis and NF-κB pathway-mediated inflammation in recurrent spontaneous abortion.
    Zhang X; Hu Y; Zhang Z; Zhang X; Liang L; Cui X; Wu Y; Hu F; Wu X
    Immun Inflamm Dis; 2023 May; 11(5):e879. PubMed ID: 37249279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 1p/19q codeletion status on extent of resection in WHO grade II glioma: Insights from a national cancer registry.
    Lu VM; Alvi MA; Bydon M; Quinones-Hinojosa A; Chaichana KL
    Clin Neurol Neurosurg; 2019 Jul; 182():32-36. PubMed ID: 31063969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.